Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microarray analysis of sarcomas.

Torsten O Nielsen1

  • 1British Columbia Cancer Agency, Vancouver Coastal Health Research Institute, and Department of Pathology, University of British Columbia, Canada. torsten@interchange.ubc.ca

Advances in Anatomic Pathology
|July 22, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synovial sarcoma reprograms transcription by GBAF activation of polycomb targets and loss of CBAF enhancers.

Nature communications·2025
Same author

The fibroblast epigenome underlies SS18::SSX-mediated transformation in synovial sarcoma.

Nature communications·2025
Same author

Chromobox 4 (CBX4) Is a Novel Interactor of SS18::SSX in Synovial Sarcoma.

Laboratory investigation; a journal of technical methods and pathology·2025
Same author

Molecular and epigenetic oncogenesis in synovial sarcoma: implications for cancer biology, diagnosis and treatment.

Oncogene·2025
Same author

DNA demethylating agents suppress preclinical models of synovial sarcoma.

The Journal of clinical investigation·2025
Same author

Prosigna Risk of Recurrence score and intrinsic subtypes are associated with adjuvant anthracycline chemotherapy benefit in high-risk breast cancer.

NPJ breast cancer·2025
Same journal

Pathobiology and Interactions of the MiTF Signaling Pathways.

Advances in anatomic pathology·2026
Same journal

Diagnosis and Reporting of Intraductal Carcinoma of the Prostate: A Guide for Practising Pathologists With Excerpts From the Genitourinary Pathology Society and the International Society of Urological Pathology Joint Expert Consultation.

Advances in anatomic pathology·2026
Same journal

An Update on Soft Tissue Tumors of the Paratesticular Region.

Advances in anatomic pathology·2026
Same journal

Recognizing Familial Thyroid Neoplasia: The Pathologist's Role in Diagnosis and Management.

Advances in anatomic pathology·2026
Same journal

Hereditary and Familial Tumor Syndromes: When to Think of Them? The Emerging Role of Pathologists as Sentinels of Genetic Cancer Predisposition.

Advances in anatomic pathology·2026
Same journal

From Familial Clustering to a Dedicated Classification: The Historical Recognition of Hereditary Tumor Syndromes in the WHO Classification of Tumors.

Advances in anatomic pathology·2026
See all related articles

Microarray analysis aids sarcoma classification and identifies potential therapeutic targets. Further validation is crucial for clinical application of these gene expression findings.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Microarray technology has been applied to sarcoma research since the early 2000s.
  • These technologies offer a broad view of molecular pathways but present challenges in specimen handling, cost, and data interpretation.
  • Microarray analyses are most impactful when addressing specific knowledge gaps in tumor biology, diagnosis, and treatment.

Purpose of the Study:

  • To review the application and impact of microarray technologies in sarcoma research.
  • To highlight the diagnostic and therapeutic insights gained from gene expression profiling in various sarcoma subtypes.
  • To discuss the challenges and future directions for microarray-based sarcoma studies.

Main Methods:

  • Gene expression profiling using microarray technology.

Related Experiment Videos

  • Bioinformatic analysis of large-scale gene expression data.
  • Correlation of molecular signatures with clinical outcomes and histopathology.

    • Main Results:

    • Microarray studies have facilitated the molecular classification of sarcomas into distinct and heterogeneous groups.
    • Diagnostic markers have been identified for specific sarcoma types, including gastrointestinal stromal tumors, synovial sarcoma, and dermatofibrosarcoma protuberans.
    • Prognostic and predictive signatures for Ewing sarcoma and osteosarcoma have been developed, alongside novel therapeutic targets like receptor tyrosine kinases.

    Conclusions:

    • Microarray analyses have significantly advanced the understanding of sarcoma molecular heterogeneity and provided valuable diagnostic tools.
    • Gene expression signatures show promise for predicting patient outcomes and guiding therapeutic strategies in sarcomas.
    • Validation of microarray findings through complementary technologies and independent studies is essential for clinical translation.